{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:43:09Z","timestamp":1778910189099,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,8,24]],"date-time":"2006-08-24T00:00:00Z","timestamp":1156377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,8,24]],"date-time":"2006-08-24T00:00:00Z","timestamp":1156377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1038\/sj.gt.3302839","type":"journal-article","created":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T11:29:32Z","timestamp":1157023772000},"page":"256-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem\/progenitor cells"],"prefix":"10.1038","volume":"14","author":[{"given":"M","family":"Yoshimitsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ramsubir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V I","family":"Rasaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Siatskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-B","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R O","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Medin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,24]]},"reference":[{"key":"BF3302839_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L . Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967; 276: 1163\u20131167.","journal-title":"N Engl J Med"},{"key":"BF3302839_CR2","first-page":"3733","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM . Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Inc.: New York, 2001, pp 3733\u20133774."},{"key":"BF3302839_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","volume":"337","author":"SC Garman","year":"2004","unstructured":"Garman SC, Garboczi DN . The molecular defect leading to Fabry disease: structure of human \u03b1-galactosidase. J Mol Biol 2004; 337: 319\u2013335.","journal-title":"J Mol Biol"},{"key":"BF3302839_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995; 333: 288\u2013293.","journal-title":"N Engl J Med"},{"key":"BF3302839_CR5","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin III HA, Sabnis S, Moore DF, Weibel T et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285: 2743\u20132749.","journal-title":"JAMA"},{"key":"BF3302839_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S et al. Safety and efficacy of recombinant human \u03b1-galactosidase A \u2013 replacement therapy in Fabry's disease. N Engl J Med 2001; 345: 9\u201316.","journal-title":"N Engl J Med"},{"key":"BF3302839_CR7","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMoa032613","volume":"350","author":"SL Staba","year":"2004","unstructured":"Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960\u20131969.","journal-title":"N Engl J Med"},{"key":"BF3302839_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","volume":"104","author":"C Peters","year":"2004","unstructured":"Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004; 104: 881\u2013888.","journal-title":"Blood"},{"key":"BF3302839_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"W Krivit","year":"1999","unstructured":"Krivit W, Peters C, Shapiro EG . Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999; 12: 167\u2013176.","journal-title":"Curr Opin Neurol"},{"key":"BF3302839_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1172\/JCI200419205","volume":"113","author":"A Biffi","year":"2004","unstructured":"Biffi A, De Palma M, Quattrini A, Del Carro U, Amadio S, Visigalli I et al. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest 2004; 113: 1118\u20131129.","journal-title":"J Clin Invest"},{"key":"BF3302839_CR11","doi-asserted-by":"publisher","first-page":"7917","DOI":"10.1073\/pnas.93.15.7917","volume":"93","author":"JA Medin","year":"1996","unstructured":"Medin JA, Tudor M, Simovitch R, Quirk JM, Jacobson S, Murray GJ et al. Correction in trans for Fabry disease: Expression, secretion, and uptake of \u03b1-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector. Proc Natl Acad Sci USA 1996; 93: 7917\u20137922.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302839_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1089\/10430349950017293","volume":"10","author":"T Takenaka","year":"1999","unstructured":"Takenaka T, Qin G, Brady RO, Medin JA . Circulating \u03b1-galactosidase A derived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry disease. Hum Gene Ther 1999; 10: 1931\u20131939.","journal-title":"Hum Gene Ther"},{"key":"BF3302839_CR13","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1073\/pnas.120177997","volume":"97","author":"T Takenaka","year":"2000","unstructured":"Takenaka T, Murray GJ, Qin G, Quirk JM, Ohshima T, Qasba P et al. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells. Proc Natl Acad Sci USA 2000; 97: 7515\u20137520.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302839_CR14","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.061020598","volume":"98","author":"G Qin","year":"2001","unstructured":"Qin G, Takenaka T, Telsch K, Kelley L, Howard T, Levade T et al. Preselective gene therapy for Fabry disease. Proc Natl Acad Sci USA 2001; 98: 3428\u20133433.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302839_CR15","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1089\/hum.1998.9.17-2629","volume":"9","author":"CE Dunbar","year":"1998","unstructured":"Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther 1998; 9: 2629\u20132640.","journal-title":"Hum Gene Ther"},{"key":"BF3302839_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0958-1669(98)80029-3","volume":"9","author":"L Naldini","year":"1998","unstructured":"Naldini L . Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 1998; 9: 457\u2013463.","journal-title":"Curr Opin Biotechnol"},{"key":"BF3302839_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1006\/mthe.2000.0077","volume":"1","author":"G Guenechea","year":"2000","unstructured":"Guenechea G, Gan OI, Inamitsu T, Dorrell C, Pereira DS, Kelly M et al. Transduction of human CD34+CD38\u2212 bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol Ther 2000; 1: 566\u2013577.","journal-title":"Mol Ther"},{"key":"BF3302839_CR18","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1182\/blood-2004-01-0045","volume":"103","author":"H Hanawa","year":"2004","unstructured":"Hanawa H, Hematti P, Keyvanfar K, Metzger ME, Krouse A, Donahue RE et al. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 2004; 103: 4062\u20134069.","journal-title":"Blood"},{"key":"BF3302839_CR19","doi-asserted-by":"publisher","first-page":"16909","DOI":"10.1073\/pnas.0407572101","volume":"101","author":"M Yoshimitsu","year":"2004","unstructured":"Yoshimitsu M, Sato T, Tao K, Walia JS, Rasaiah VI, Sleep GT et al. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci USA 2004; 101: 16909\u201316914.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302839_CR20","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1096\/fj.05-4006fje","volume":"19","author":"C Siatskas","year":"2005","unstructured":"Siatskas C, Underwood J, Ramezani A, Hawley RG, Medin JA . Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates antiapoptotic and proliferative mechanisms. FASEB J 2005; 19: 1752\u20131754.","journal-title":"FASEB J"},{"key":"BF3302839_CR21","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","volume":"94","author":"T Ohshima","year":"1997","unstructured":"Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO et al. \u03b1-Galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci USA 1997; 94: 2540\u20132544.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302839_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1086\/316953","volume":"68","author":"YA Ioannou","year":"2001","unstructured":"Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ . Fabry disease: preclinical studies demonstrate the effectiveness of \u03b1-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet 2001; 68: 14\u201325.","journal-title":"Am J Hum Genet"},{"key":"BF3302839_CR23","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1073\/pnas.051634498","volume":"98","author":"SC Jung","year":"2001","unstructured":"Jung SC, Han IP, Limaye A, Xu R, Gelderman MP, Zerfas P et al. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proc Natl Acad Sci USA 2001; 98: 2676\u20132681.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302839_CR24","first-page":"3573","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"HW Moser","year":"2001","unstructured":"Moser HW, Linke T, Fensom AH, Levade T, Sandhoff K . Acid ceramidase deficiency: Farber lipogranulomatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Inc.: New York, 2001, pp 3573\u20133588."},{"key":"BF3302839_CR25","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1089\/10430349950018003","volume":"10","author":"JA Medin","year":"1999","unstructured":"Medin JA, Takenaka T, Carpentier S, Garcia V, Basile JP, Segui B et al. Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells. Hum Gene Ther 1999; 10: 1321\u20131329.","journal-title":"Hum Gene Ther"},{"key":"BF3302839_CR26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V74.2.872.872","volume":"74","author":"P Mauch","year":"1989","unstructured":"Mauch P, Hellman S . Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood 1989; 74: 872\u2013875.","journal-title":"Blood"},{"key":"BF3302839_CR27","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0301-472X(99)00050-8","volume":"27","author":"T Takenaka","year":"1999","unstructured":"Takenaka T, Hendrickson CS, Tworek DM, Tudor M, Schiffmann R, Brady RO et al. Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem\/progenitor and stromal cells derived from patients with Fabry disease. Exp Hematol 1999; 27: 1149\u20131159.","journal-title":"Exp Hematol"},{"key":"BF3302839_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1525-0016(02)90720-3","volume":"5","author":"L Ailles","year":"2002","unstructured":"Ailles L, Schmidt M, Santoni de Sio FR, Glimm H, Cavalieri S, Bruno S et al. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD\/SCID repopulating hematopoietic cells. Mol Ther 2002; 5: 615\u2013626.","journal-title":"Mol Ther"},{"key":"BF3302839_CR29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH . Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38: 750\u2013760.","journal-title":"J Med Genet"},{"key":"BF3302839_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.1068893","volume":"296","author":"Z Li","year":"2002","unstructured":"Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497.","journal-title":"Science"},{"key":"BF3302839_CR31","doi-asserted-by":"publisher","first-page":"13777","DOI":"10.1073\/pnas.222221899","volume":"99","author":"H Takahashi","year":"2002","unstructured":"Takahashi H, Hirai Y, Migita M, Seino Y, Fukuda Y, Sakuraba H et al. Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer. Proc Natl Acad Sci USA 2002; 99: 13777\u2013137872.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302839_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","volume":"9","author":"RJ Zielger","year":"2004","unstructured":"Zielger RJ, Lonning SM, Armentano D, Li C, Souza DW, Cherry M et al. AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of \u03b1-galactosidase A and induction of immune tolerance in Fabry mice. Mol Ther 2004; 9: 231\u2013240.","journal-title":"Mol Ther"},{"key":"BF3302839_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jgm.468","volume":"6","author":"M Przybylska","year":"2004","unstructured":"Przybylska M, Wu IH, Zhao H, Ziegler RJ, Tousignant JD, Desnick RJ et al. Partial correction of the \u03b1-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors. J Gene Med 2004; 6: 85\u201392.","journal-title":"J Gene Med"},{"key":"BF3302839_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0925-4439(98)00012-X","volume":"1406","author":"R Kase","year":"1998","unstructured":"Kase R, Simmoto M, Itoh K, Utsumi K, Kotani M, Taya C et al. Immunohistochemical characterization of transgenic mice highly expressing human lysosomal \u03b1-galactosidase. Biochim Biophys Acta 1998; 1406: 260\u2013266.","journal-title":"Biochim Biophys Acta"},{"key":"BF3302839_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa012616","volume":"346","author":"S Hacein-Bey-Abina","year":"2002","unstructured":"Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185\u20131193.","journal-title":"N Engl J Med"},{"key":"BF3302839_CR36","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1126\/science.1070104","volume":"296","author":"A Aiuti","year":"2002","unstructured":"Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002; 296: 2410\u20132413.","journal-title":"Science"},{"key":"BF3302839_CR37","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","volume":"364","author":"HB Gasper","year":"2004","unstructured":"Gasper HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004; 364: 2181\u20132187.","journal-title":"Lancet"},{"key":"BF3302839_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJM200301163480314","volume":"348","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255\u2013256.","journal-title":"N Engl J Med"},{"key":"BF3302839_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415\u2013419.","journal-title":"Science"},{"key":"BF3302839_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","volume":"110","author":"AR Schroder","year":"2002","unstructured":"Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002; 110: 521\u2013529.","journal-title":"Cell"},{"key":"BF3302839_CR41","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.1083413","volume":"300","author":"X Wu","year":"2003","unstructured":"Wu X, Li Y, Crise B, Burgess SM . Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749\u20131751.","journal-title":"Science"},{"key":"BF3302839_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2004.04.040","volume":"318","author":"EY Kim","year":"2004","unstructured":"Kim EY, Hong YB, Lai Z, Kim HJ, Cho YH, Brady RO et al. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease. Biochem Biophys Res Commun 2004; 318: 381\u2013390.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302839_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ymthe.2004.03.013","volume":"9","author":"AA Hofling","year":"2004","unstructured":"Hofling AA, Devine S, Vogler C, Sands MS . Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease. Mol Ther 2004; 9: 856\u2013865.","journal-title":"Mol Ther"},{"key":"BF3302839_CR44","volume-title":"Molecular cloning. A laboratory manual","author":"J Sambrook","year":"2001","unstructured":"Sambrook J, Russell DW . Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2001."},{"key":"BF3302839_CR45","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood.V77.12.2597.2597","volume":"77","author":"T Tanaka","year":"1991","unstructured":"Tanaka T, Suda T, Suda J, Inoue T, Hirabayashi Y, Hirai H et al. Stimulatory effects of G-CSF on colony-forming units-spleen (CFU-S) differentiation and pre-CFU-S proliferation in mice. Blood 1991; 77: 2597\u20132602.","journal-title":"Blood"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302839","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:29:57Z","timestamp":1648614597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,24]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["BF3302839"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302839","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,24]]},"assertion":[{"value":"22 September 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}